Aldeyra Therapeutics Inc (NASDAQ:ALDX)
| 8.51 Delayed Data As of Sep 24 |  +0.11 / +1.31%Today’s Change | 6.21 Today|||52-Week Range 15.95 | +24.05% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -12.1M | -18.7M | -22.3M | -38.9M | |
| Depreciation | 18.8K | 35.8K | 37.8K | 71.0K | ||
| Total Other Cash Flow | 2.2M | 3.1M | 2.7M | 4.0M | ||
| Funds From Operations | -9.9M | -15.6M | -19.6M | -34.9M | ||
| Funds From/For Other Operating Expenses | -536.8K | -463.0K | -215.5K | -5.0M | ||
| Net Cash Flow - Operating Activities | -9.3M | -15.1M | -19.4M | -29.9M | ||
| Investing | Increase In Investments | -13.0M | -16.0M | -35.1M | -59.7M | |
| Decrease In Investments | 0.00 | 15.8M | 24.9M | 36.7M | ||
| Capital Expenditures | -86.1K | -11.8K | -24.8K | -263.0K | ||
| Net Cash Flow Investing | -13.0M | -225.2K | -10.2M | -23.3M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 28.5M | 12.7M | 37.5M | 81.9M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 125.3K | 0.00 | ||
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 1.4M | ||
| Net Cash Flow - Financing | 28.5M | 12.7M | 37.6M | 80.5M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 6.1M | -2.6M | 8.0M | 27.3M | ||
